Report Detail
Global Eosinophilic Esophagitis Drug Market Growth 2019-2024
- RnM3064922 |
- 06 March, 2019 |
- Global |
- 163 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.
Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant role. The treatment may consist of removal of known or suspected triggers and medication to suppress the immune response.
This report studies the eosinophilic esophagitis drug market.
The classification of eosinophilic esophagitis drug includes budesonide, fluticasone and other types, and the proportion of budesonide in 2017 is about 52%.
North America is the largest consumption region of eosinophilic esophagitis drug, with a sales market share nearly 32% in 2017. Europe is the second largest consumption region of eosinophilic esophagitis drug, enjoying Sales market share nearly 29% in 2017.
Market competition is intense. AstraZeneca, GSK, Bayer are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Eosinophilic Esophagitis Drug market will register a 6.2% CAGR in terms of revenue, the global market size will reach US$ 150 million by 2024, from US$ 100 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Eosinophilic Esophagitis Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Eosinophilic Esophagitis Drug market by product type, application, key manufacturers and key regions and countries.
This study considers the Eosinophilic Esophagitis Drug value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Budesonide
Fluticasone
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
Drugstore
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
GSK
Bayer
Adare Pharmaceuticals
DBV Technologies
Dr. Falk Pharma
Quorum Innovations
Shire
Calypso
Celgene
Regeneron
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Eosinophilic Esophagitis Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Eosinophilic Esophagitis Drug market by identifying its various subsegments.
Focuses on the key global Eosinophilic Esophagitis Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Eosinophilic Esophagitis Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Eosinophilic Esophagitis Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Eosinophilic Esophagitis Drug Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Eosinophilic Esophagitis Drug Consumption 2014-2024
- 2.1.2 Eosinophilic Esophagitis Drug Consumption CAGR by Region
- 2.2 Eosinophilic Esophagitis Drug Segment by Type
- 2.2.1 Budesonide
- 2.2.2 Fluticasone
- 2.2.3 Others
- 2.3 Eosinophilic Esophagitis Drug Consumption by Type
- 2.3.1 Global Eosinophilic Esophagitis Drug Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Eosinophilic Esophagitis Drug Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Eosinophilic Esophagitis Drug Sale Price by Type (2014-2019)
- 2.4 Eosinophilic Esophagitis Drug Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Clinics
- 2.4.3 Drugstore
- 2.5 Eosinophilic Esophagitis Drug Consumption by Application
- 2.5.1 Global Eosinophilic Esophagitis Drug Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Eosinophilic Esophagitis Drug Value and Market Share by Application (2014-2019)
- 2.5.3 Global Eosinophilic Esophagitis Drug Sale Price by Application (2014-2019)
3 Global Eosinophilic Esophagitis Drug by Players
- 3.1 Global Eosinophilic Esophagitis Drug Sales Market Share by Players
- 3.1.1 Global Eosinophilic Esophagitis Drug Sales by Players (2017-2019)
- 3.1.2 Global Eosinophilic Esophagitis Drug Sales Market Share by Players (2017-2019)
- 3.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Players
- 3.2.1 Global Eosinophilic Esophagitis Drug Revenue by Players (2017-2019)
- 3.2.2 Global Eosinophilic Esophagitis Drug Revenue Market Share by Players (2017-2019)
- 3.3 Global Eosinophilic Esophagitis Drug Sale Price by Players
- 3.4 Global Eosinophilic Esophagitis Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Eosinophilic Esophagitis Drug Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Eosinophilic Esophagitis Drug Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Eosinophilic Esophagitis Drug by Regions
- 4.1 Eosinophilic Esophagitis Drug by Regions
- 4.1.1 Global Eosinophilic Esophagitis Drug Consumption by Regions
- 4.1.2 Global Eosinophilic Esophagitis Drug Value by Regions
- 4.2 Americas Eosinophilic Esophagitis Drug Consumption Growth
- 4.3 APAC Eosinophilic Esophagitis Drug Consumption Growth
- 4.4 Europe Eosinophilic Esophagitis Drug Consumption Growth
- 4.5 Middle East & Africa Eosinophilic Esophagitis Drug Consumption Growth
5 Americas
- 5.1 Americas Eosinophilic Esophagitis Drug Consumption by Countries
- 5.1.1 Americas Eosinophilic Esophagitis Drug Consumption by Countries (2014-2019)
- 5.1.2 Americas Eosinophilic Esophagitis Drug Value by Countries (2014-2019)
- 5.2 Americas Eosinophilic Esophagitis Drug Consumption by Type
- 5.3 Americas Eosinophilic Esophagitis Drug Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Eosinophilic Esophagitis Drug Consumption by Countries
- 6.1.1 APAC Eosinophilic Esophagitis Drug Consumption by Countries (2014-2019)
- 6.1.2 APAC Eosinophilic Esophagitis Drug Value by Countries (2014-2019)
- 6.2 APAC Eosinophilic Esophagitis Drug Consumption by Type
- 6.3 APAC Eosinophilic Esophagitis Drug Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Eosinophilic Esophagitis Drug by Countries
- 7.1.1 Europe Eosinophilic Esophagitis Drug Consumption by Countries (2014-2019)
- 7.1.2 Europe Eosinophilic Esophagitis Drug Value by Countries (2014-2019)
- 7.2 Europe Eosinophilic Esophagitis Drug Consumption by Type
- 7.3 Europe Eosinophilic Esophagitis Drug Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Eosinophilic Esophagitis Drug by Countries
- 8.1.1 Middle East & Africa Eosinophilic Esophagitis Drug Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Eosinophilic Esophagitis Drug Value by Countries (2014-2019)
- 8.2 Middle East & Africa Eosinophilic Esophagitis Drug Consumption by Type
- 8.3 Middle East & Africa Eosinophilic Esophagitis Drug Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Eosinophilic Esophagitis Drug Distributors
- 10.3 Eosinophilic Esophagitis Drug Customer
11 Global Eosinophilic Esophagitis Drug Market Forecast
- 11.1 Global Eosinophilic Esophagitis Drug Consumption Forecast (2019-2024)
- 11.2 Global Eosinophilic Esophagitis Drug Forecast by Regions
- 11.2.1 Global Eosinophilic Esophagitis Drug Forecast by Regions (2019-2024)
- 11.2.2 Global Eosinophilic Esophagitis Drug Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Eosinophilic Esophagitis Drug Forecast by Type
- 11.8 Global Eosinophilic Esophagitis Drug Forecast by Application
12 Key Players Analysis
- 12.1 AstraZeneca
- 12.1.1 Company Details
- 12.1.2 Eosinophilic Esophagitis Drug Product Offered
- 12.1.3 AstraZeneca Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 AstraZeneca News
- 12.2 GSK
- 12.2.1 Company Details
- 12.2.2 Eosinophilic Esophagitis Drug Product Offered
- 12.2.3 GSK Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 GSK News
- 12.3 Bayer
- 12.3.1 Company Details
- 12.3.2 Eosinophilic Esophagitis Drug Product Offered
- 12.3.3 Bayer Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Bayer News
- 12.4 Adare Pharmaceuticals
- 12.4.1 Company Details
- 12.4.2 Eosinophilic Esophagitis Drug Product Offered
- 12.4.3 Adare Pharmaceuticals Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Adare Pharmaceuticals News
- 12.5 DBV Technologies
- 12.5.1 Company Details
- 12.5.2 Eosinophilic Esophagitis Drug Product Offered
- 12.5.3 DBV Technologies Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 DBV Technologies News
- 12.6 Dr. Falk Pharma
- 12.6.1 Company Details
- 12.6.2 Eosinophilic Esophagitis Drug Product Offered
- 12.6.3 Dr. Falk Pharma Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Dr. Falk Pharma News
- 12.7 Quorum Innovations
- 12.7.1 Company Details
- 12.7.2 Eosinophilic Esophagitis Drug Product Offered
- 12.7.3 Quorum Innovations Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Quorum Innovations News
- 12.8 Shire
- 12.8.1 Company Details
- 12.8.2 Eosinophilic Esophagitis Drug Product Offered
- 12.8.3 Shire Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Shire News
- 12.9 Calypso
- 12.9.1 Company Details
- 12.9.2 Eosinophilic Esophagitis Drug Product Offered
- 12.9.3 Calypso Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Calypso News
- 12.10 Celgene
- 12.10.1 Company Details
- 12.10.2 Eosinophilic Esophagitis Drug Product Offered
- 12.10.3 Celgene Eosinophilic Esophagitis Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Celgene News
- 12.11 Regeneron
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Eosinophilic Esophagitis Drug . Industry analysis & Market Report on Eosinophilic Esophagitis Drug is a syndicated market report, published as Global Eosinophilic Esophagitis Drug Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Eosinophilic Esophagitis Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
